相似文献
1
Use of a multi-gene pharmacogenetic panel reduces adverse drug effects.
Cell Rep Med. 2023 May 16;4(5):101021. doi: 10.1016/j.xcrm.2023.101021. Epub 2023 Apr 20.
2
Genotype-guided drug prescribing vs. usual care reduced clinically relevant adverse drug reactions at 12 wk.
Ann Intern Med. 2023 Jun;176(6):JC70. doi: 10.7326/J23-0031. Epub 2023 Jun 6.
3
A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions.
Pharmacoeconomics. 2016 Aug;34(8):771-93. doi: 10.1007/s40273-016-0397-9.
4
[Use of pharmacogenetic testing to prevent adverse drug reactions during statin therapy].
Ter Arkh. 2017;89(1):82-87. doi: 10.17116/terarkh201789182-87.
5
Interpreting and Implementing Clinical Pharmacogenetic Tests: Perspectives From Service Providers.
Clin Pharmacol Ther. 2019 Aug;106(2):298-301. doi: 10.1002/cpt.1494. Epub 2019 Jun 4.
6
Genomic Variation and Pharmacokinetics in Old Age: A Quantitative Review of Age- vs. Genotype-Related Differences.
Clin Pharmacol Ther. 2019 Mar;105(3):625-640. doi: 10.1002/cpt.1057. Epub 2018 Apr 2.
7
Pharmacogenetics-based personalized therapy: Levels of evidence and recommendations from the French Network of Pharmacogenetics (RNPGx).
Therapie. 2017 Apr;72(2):185-192. doi: 10.1016/j.therap.2016.09.014. Epub 2017 Jan 30.
8
Experience with comprehensive pharmacogenomic multi-gene panel in clinical practice: a retrospective single-center study.
Croat Med J. 2022 Jun 22;63(3):257-264. doi: 10.3325/cmj.2022.63.257.
9
Considerations of pharmacogenetic testing in children.
Pharmacogenomics. 2016 Jun;17(9):975-7. doi: 10.2217/pgs-2016-0073. Epub 2016 Jun 1.
10
Pharmacogenomics: Prescribing Precisely.
Med Clin North Am. 2019 Nov;103(6):977-990. doi: 10.1016/j.mcna.2019.07.002. Epub 2019 Aug 24.
引用本文的文献
1
Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE Study.
Clin Pharmacol Ther. 2025 Oct;118(4):803-812. doi: 10.1002/cpt.3749. Epub 2025 Jun 24.
2
Scoping review of enablers and challenges of implementing pharmacogenomics testing in the primary care settings.
BMJ Open. 2024 Nov 5;14(11):e087064. doi: 10.1136/bmjopen-2024-087064.
3
A Pharmacogenetic Panel-Based Prediction of the Clinical Outcomes in Elderly Patients with Coronary Artery Disease.
Pharmaceutics. 2024 Aug 17;16(8):1079. doi: 10.3390/pharmaceutics16081079.
本文引用的文献
1
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
Lancet. 2023 Feb 4;401(10374):347-356. doi: 10.1016/S0140-6736(22)01841-4.
2
Moving Pharmacogenetics Into Practice: It's All About the Evidence!
Clin Pharmacol Ther. 2021 Sep;110(3):649-661. doi: 10.1002/cpt.2327. Epub 2021 Jul 7.
3
Pharmacogenetics in Practice: Estimating the Clinical Actionability of Pharmacogenetic Testing in Perioperative and Ambulatory Settings.
Clin Transl Sci. 2020 May;13(3):618-627. doi: 10.1111/cts.12748. Epub 2020 Feb 12.
4
Pharmacogenomics.
Lancet. 2019 Aug 10;394(10197):521-532. doi: 10.1016/S0140-6736(19)31276-0. Epub 2019 Aug 5.
5
Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping.
Clin Pharmacol Ther. 2012 Aug;92(2):235-42. doi: 10.1038/clpt.2012.66. Epub 2012 Jun 27.
6
Pharmacogenetics: from bench to byte--an update of guidelines.
Clin Pharmacol Ther. 2011 May;89(5):662-73. doi: 10.1038/clpt.2011.34. Epub 2011 Mar 16.
7
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.
Clin Pharmacol Ther. 2011 Mar;89(3):464-7. doi: 10.1038/clpt.2010.279. Epub 2011 Jan 26.
Zotero 插件